Sort
51,593 grants matching “hepatitis”
In silico identification of phyto-therapies
$379,655Indra N Sarkar · Brown University · R01 · FY2015 · LM
Community Outreach and Engagement
$379,609Moon S Chen · University Of California At Davis · P30 · FY2021 · CA
Adult to adult living donor liver transplantation cohor*
$379,606James F. Trotter · University Of Colorado Denver · U01 · FY2007 · DK
Core 3: Population & Data Modeling
$379,570Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2023 · DA
Mechanisms for Arsenic-Induced Vascular Disease
$379,561Aaron Barchowsky · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · ES
Point-of-care magnetofluidic HCV diagnostic using thermally responsive valves
$379,560Ian M White · Univ Of Maryland, College Park · R01 · FY2025 · AI
Evolution of Virus-Host Interactions
$379,546John Yin · University Of Wisconsin-Madison · R01 · FY2012 · AI
Novel Anti-Diabetic Actions of Hypothalamic FGF19-FGFR1 Signaling
$379,538Michael W Schwartz · University Of Washington · R01 · FY2015 · DK
Ricin-Mechanism, Transition State and Inhibitor Design
$379,534Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2010 · CA
REGULATION OF NET HEPATIC GLUCOSE UPTAKE IN VIVO
$379,519Vanderbilt University · R01 · FY2000 · DK
Apolipoprotein A-V: A Functional Proteomics Study
$379,509Robert O'Mara Ryan · Children'S Hospital & Res Ctr At Oakland · R01 · FY2007 · HL
New Targets of Thyroid Hormone Action
$379,505Anthony N Hollenberg · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK
Regulation of polycystin-2 channel activity
$379,492Titus Jonathon Boggon · Yale University · R01 · FY2013 · DK
Control of Effector and Memory T Cell Development by Inflammatory Signals
$379,454Susan M Kaech · Yale University · R01 · FY2012 · AI
GENE THERAPY FOR DYSLIPIDEMIAS
$379,448Daniel James Rader · University Of Pennsylvania · P01 · FY2013 · HL
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis
$379,439Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2013 · AA
Development and Validation of a Zebrafish Model for Vanishing White Matter Disease
$379,420Josh Leitch Bonkowsky · University Of Utah · R33 · FY2022 · NS
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASE
$379,416University Of California San Francisco · R01 · FY2001 · DK
Optical and electromagnetic tracking guidance for hepatic interventions
$379,411Umar Mahmood · Massachusetts General Hospital · U01 · FY2018 · CA
Prospective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapy
$379,411Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · DK
Hepatitis C virus escape mechanisms from innate immunity
$379,384Ranjit Ray · Washington University · U54 · FY2009 · AI
Effect of HBV DNA Methylation and the Mutant 1762T/1764A on Viral Load and HCC
$379,361Kathleen Schwarz · Johns Hopkins University · U01 · FY2010 · DK
Longitudinal cohort of newly acquired HCV infection
$379,345John M Kaldor · University Of New South Wales · R01 · FY2007 · DA
Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome
$379,329William Todd Cade · Washington University · R01 · FY2016 · HL
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 8/9
$379,324Mack Clarence Mitchell · Ut Southwestern Medical Center · U01 · FY2020 · AA